|
Gene | Expressing cells in lung | Gene function | Mutated domain | Effect of mutation | Pathological process |
|
SFTPC |
AEC type II [107] |
Component of surfactant fluid Lower surface tension [107] | Linker domain associates with LB [31] |
Toxic gain of function [107] | Alteration of trafficking, dysregulation of proteostasis [31] Alteration of surfactant lipid composition [31] |
C-terminal BRICHOS domain folded in ER and GA [108] |
ER stress and UPR upregulation [109–111] Activation of immune cells [112] Alteration of surfactant lipid composition [112] |
|
SFTPA2 | AEC type II Clara/club cell Submucosal gland [113–116] | Collectin (to modulate innate and adaptive immunity) [107, 117] | Carbohydrate-recognition domain [32] | Toxic gain of function [118] | Increase of ER stress [118] UPR upregulation [35, 119] |
|
ABCA3 | AEC type II [120] | Limiting membrane protein of lamellar body [107] | Intracellular loop, extracellular domain 2 [45, 46, 121] | Loss of function Toxic gain of function [107] | Abnormal surfactant processing/trafficking [45, 122] Loss of epithelial function [41] Increase of ER stress [41, 44] |
|
TERT | AEC type II [123] Lung fibroblasts [124, 125] Lung epithelial cells [126] | Enzyme in telomerase complex maintaining telomere length [127–130] | All [55, 56, 60, 131–135] | Haploinsufficiency [56, 136, 137] | Telomere shortening [55, 56, 61, 62, 124, 131, 138, 139] |
|
TERC | AEC type II [70, 123, 140] Lung fibroblasts [124, 125] | Template in telomerase complex [127–130] | Pseudoknot, CR4-CR5, and ScaRNA domains [55, 56, 61, 133, 139, 141, 142] | Haploinsufficiency [136, 137, 143, 144] | Telomere shortening [55, 56, 61, 124, 131, 138] |
|
DKC1 | Lung tissue [145] | Dyskerin (stabilizes template in telomerase complex) [64] | Near RNA-binding domain [64], near N-terminus [146–149] | X-linked loss of function [64] | Telomere shortening [64] Decrease in TERC [146] |
|
TINF2 | Lung tissue [150] | Telomere maintenance by shelterin complex [151] | Exon 6 residues 269–298 [63, 152, 153] | Dominant negative [63] | Telomere shortening [63] |
|
RTEL1 | Not detectable in lungs [154, 155] | DNA helicase, telomere T-loop, and G4 unwinding [156] | Various domains, that is, helicase and harmonin [65–67, 157] | Haploinsufficiency [66] | Telomere shortening [65–67] |
|
PARN | Lung tissue [158] | Exoribonuclease controls mRNA stability [159] | Mainly CAF1 ribonuclease domain [67] | Haploinsufficiency [67] | Telomere shortening [67] Reduction of DKC1, TERT, TERC, and TERF1 [159] |
|